Florida Urology Partners

Tampa, Florida 33615

3 studies enrolling now · 31 studies all time

What they study most

Benign Prostatic Hyperplasia, Biochemical Recurrence of Malignant Neoplasm of Prostate, Bladder Cancer, Bladder Pain Syndrome, Cancer of Prostate, Enteric Hyperoxaluria, Fecal Incontinence, Healthy Volunteers, Hypogonadism, Interstitial Cystitis, Localized Prostate Cancer, Lower Urinary Tract Symptoms (LUTS)

Studies at this site

• Copper Cu 64 PSMA I&T PET Imaging in Men With Newly Diagnosed Prostate Cancer — Recruiting now
• Post-Approval Study of the Neuspera Sacral Neuromodulation System — Recruiting now
• A Safety and Dose-finding Study of PRL-02 Depot in Men With Advanced Prostate Cancer — Recruiting now
• Safety and Efficacy Study of VNX001 Compared to Its Individual Components (Lidocaine and Heparin) or Placebo in Subjects With IC/BPS — Recruiting now
• Optilume™ BPH Catheter System in Men With Symptomatic BPH — Running, not enrolling
• OPtilume™ BPH Catheter SystEm for Treatment of Men eXperiencing Symptomatic BPH — Running, not enrolling
• RESTORE: An RCT to Evaluate the Efficacy of the Revi System — Running, not enrolling
• ResQ132EX-NMIBC: Expanded Access Use of Recombinant Bacillus Calmette-Guérin in Nonmuscle Invasive Bladder Cancer — Available (expanded access)
• WATER IV Prostate Cancer — Running, not enrolling
• Copper Cu 64 PSMA I&T PET Imaging in Men With Suspected Recurrence of Prostate Cancer — Completed
• ADSTILADRIN Early Utilization and Outcomes in the Real World Setting — Stopped early
• Axonics SacRal NeuromodulaTIon System RegisTRY Study — Completed
• BlueWind RENOVA iStim™ System for the Treatment of OAB — Completed
• Phase 3 Study of ProstAtak® Immunotherapy With Standard Radiation Therapy for Localized Prostate Cancer — Running, not enrolling
• InterStim Micro Post Market Clinical Follow-up Study (ELITE) — Stopped early
• Composur: Study to Understand the Performance of Vibegron in Participants with Overactive Bladder (OAB) — Completed
• CAN-Stim Compared to SNS in Treatment of Urinary Urgency Incontinence With Wireless Neuromodulation Technology — Status unconfirmed
• Study of Focal Ablation of the Prostate With NanoTherm® Therapy System for Intermediate-Risk Prostate Cancer — Stopped early
• Safety, Tolerability, and Pharmacodynamics of NOV-001 in Adult Subjects — Stopped early
• A Study to Evaluate Androderm®'s Effect on Blood Pressure in Adult Hypogonodal Male Participants — Completed
• PROCLAIM: Germline Genetic Testing for Prostate Cancer Patients — Completed
• A Trial Comparing Cardiovascular Safety of Degarelix Versus Leuprolide in Patients With Advanced Prostate Cancer and Cardiovascular Disease — Stopped early
• Vesair Clinical Trial — Stopped early
• InterStim Basic Evaluation Lead Post-Market Clinical Follow-up Study — Completed
• Effects and Safety of OPK-88004 Doses in Men With Signs and Symptoms of Benign Prostatic Hyperplasia (BPH) — Stopped early
• Prospective US Radiofrequency SUI Trial — Status unconfirmed
• InterStim® Amplitude Study — Completed
• Safety and Efficacy Study of Cefepime-AAI101 in the Treatment of Complicated Urinary Tract Infections — Completed
• A Study to Assess LY01005 Versus Goserelin Comparator (ZOLADEX®) in Patients With Prostate Cancer — Completed
• A Clinical Study in Patients With Overactive Bladder With Leakage of Urine, to Find Out if the Medicine, Fesoterodine, Works in Those Patients Who Did Not Have Enough Response to the Medicine, Tolterodine. — Completed
• A Trial of Degarelix in Men With Lower Urinary Tract Symptoms (LUTS) Associated With Benign Prostatic Hyperplasia (BPH) — Completed